Balaji

I really enjoyed co-mentoring Arianny Mordan this summer, a talented student from the Workforce Development Program
@danafarber.bsky.social. She gifted me a mug, but I’m too embarrassed to use it!
Excited to see all you’ll accomplish, Arianny!

Thanks to @mishabeltran.bsky.social for the support.

Excited to share our new study in 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝!
We focus on PROX1 as a key driver of neuroendocrine #ProstateCancer and highlight its potential as a therapeutic target.
Huge thanks to @mishabeltran.bsky.social for her mentorship!

bit.ly/3HRIvAU

@aacrjournals.bsky.social

Thank you for highlighting our recent work published in Cancer Research @aacrjournals.bsky.social!

@mishabeltran.bsky.social

Honored to give 2 talks last week at the Gordon: Hormone-Dependent Cancers!
Huge thanks to organizers for the invitation.
Special thanks to my mentor, @mishabeltran.bsky.social, for her incredible support.

Loved learning, sharing ideas, and feeling the warmth of this amazing #GRC community.

Targeting the tumour cell surface in advanced prostate cancer - Nature Reviews Urology This Review provides an overview of the main targetable surface proteins in prostate cancer, defined as the surfaceome, discussing the mechanisms of action and efficacy of currently available drugs ta...

Big thanks to Johann de Bono and @mishabeltran.bsky.social for the chance to contribute to a timely review on Cell Surface Targets in #ProstateCancer, now out in @natrevurol.bsky.social!
Had a wonderful time learning and collaborating with Cristina Boixareu Fiol and Tarek Taha.
bit.ly/42cCWTX

Lineage-Specific EZH2 Activity in Advanced Prostate Cancer Subtypes - Varadha Balaji Venkadakrishnan Varadha Balaji Venkadakrishnan joins Andrea Miyahira to discuss research examining EZH2's lineage-specific activity in advanced prostate cancer subtypes. His work explores how this histone modifier fu...

I am grateful to UroToday+GUOncToday for hosting me on their digital platform. It was a wonderful opportunity to share insights on our recent publication about EZH2 activity in advanced #ProstateCancer subtypes. Thank you for the support!

#BeltranLab
bit.ly/418kjQe